DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
Iodo ( DrugBank:
iodo
)
1 disease
告示番号
疾患名
(ページ内リンク)
臨床試験数
28
全身性アミロイドーシス
2
28. 全身性アミロイドーシス
臨床試験数
:
267
/
薬物数
:
241
- (
DrugBank
:
77
) /
標的遺伝子数
:
68
-
標的パスウェイ数
:
180
10
50
100
ALL
diseases per page:
Showing 1 to 2 of 2 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT00030381
(
ClinicalTrials.gov
)
December 2001
14/2/2002
Iodo
doxorubicin in Treating Patients With Primary Systemic Amyloidosis
Phase I Trial of 4'-
IODO
-4'-Deoxydoxorubicin in Primary Amyloidosis (AL)
Primary Systemic Amyloidosis
Drug: 4'-
iodo
-4'-deoxydoxorubicin;Other: pharmacological study
National Cancer Institute (NCI)
NULL
Terminated
18 Years
N/A
Both
22
Phase 1
United States
2
NCT00003853
(
ClinicalTrials.gov
)
April 1999
1/11/1999
4'-
Iodo
-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis
Phase II Trial of 4'-
IODO
-4'-Deoxydoxorubicin in Primary Amyloidosis (AL)
Multiple Myeloma and Plasma Cell Neoplasm
Drug: 4'-
iodo
-4'-deoxydoxorubicin
National Cancer Institute (NCI)
NULL
Completed
18 Years
N/A
Both
45
Phase 2
United States;Italy